The global transforming growth factor beta market is anticipated to grow at a significant CAGR during the forecast period. Transforming growth factor (TGF) beta is molecules that are inhibited from the TGF-beta family. It is a highly pleiotropic cytokine and plays an important role in wound healing, angiogenesis, and cancer. The major factor driving the market growth is the rising prevalence of cancer across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/transforming-growth-factor-beta-market
According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Additionally, the most common cancers are breast cancer, lung and bronchus cancer, and leukemia, among others. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers include breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020.
Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of cancer is increasing the demand for transforming growth factor betas to treat cancer progression, which in turn, is driving the growth of the market. Some key players in the market include Novartis International AG, and Eli Lilly and Co., among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Novartis International AG, and Eli Lilly and Co., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Transforming Growth Factor Beta Market Report by Segment
By Type
- Beta 1
- Beta 2
- Beta 3
- Beta 4
By Application
- Wound Healing
- Angiogenesis
- Cancer
- Others
A full report of Transforming Growth Factor Beta Market is available at: https://www.omrglobal.com/industry-reports/transforming-growth-factor-beta-market
Transforming Growth Factor Beta Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Novartis International AG
- Eli Lilly and Co.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
